skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines epoetin betaQuestion & answer

epoetin beta · Medicine question

What is the shelf life of NeoRecormon (epoetin beta) pre-filled syringes?

iatroX medicinesPublished 8 November 2026

The answer

Answer

NeoRecormon (epoetin beta) pre-filled syringes have a shelf life of 2 years.

Sources for this answer

Neorecormon Solution for Injection in Pre-Filled SyringeRoche Products Limited · emc · SmPC §6.3 Shelf life · Version 31Document updated 16 September 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about epoetin beta

How long and at what temperature can NeoRecormon (epoetin beta) pre-filled syringes be stored outside the refrigerator for ambulatory use?How much polysorbate 20 is present in NeoRecormon (epoetin beta) pre-filled syringes with nominal volumes of 0.3 ml and 0.6 ml?What pack sizes are listed for NeoRecormon (epoetin beta) 30,000 IU pre-filled syringes?Can a NeoRecormon (epoetin beta) pre-filled syringe be used for more than one dose?What should the solution in a NeoRecormon (epoetin beta) pre-filled syringe look like before injection?

epoetin beta

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the epoetin beta guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

By which injection routes can NeoRecormon (epoetin beta) be administered for symptomatic anaemia in patients with chronic renal failure?